Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Zamudio Vázquez, Rubí et al., 2015
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/158574

A new quinoxaline-containing peptide induces apoptosis in cancer cells by autophagy modulation

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

The synthesis of a new small library of quinoxaline-containing peptides is described. After cytotoxic evaluation in four human cancer cell lines, as well as detailed biological studies, it was found that the most active compound, RZ2, promotes the formation of acidic compartments, where it accumulates, blocking the progression of autophagy. Further disruption of the mitochondrial membrane potential and an increase in mitochondrial ROS was observed, causing cells to undergo apoptosis. Given its cytotoxic activity and protease-resistant features, RZ2 could be a potential drug candidate for cancer treatment and provide a basis for future research into the crosstalk between autophagy and apoptosis and its relevance in cancer therapy.

Citació

Citació

ZAMUDIO VÁZQUEZ, Rubí, IVANOVA, Saška, MORENO, Miguel, HERNÁNDEZ-ALVAREZ, María isabel, GIRALT LLEDÓ, Ernest, BIDON-CHANAL BADIA, Axel, ZORZANO OLARTE, Antonio, ALBERICIO PALOMERA, Fernando, TULLA-PUCHE, Judit. A new quinoxaline-containing peptide induces apoptosis in cancer cells by autophagy modulation. _Chemical Science_. 2015. Vol. 6, núm. 4537-4549. [consulta: 21 de gener de 2026]. ISSN: 2041-6520. [Disponible a: https://hdl.handle.net/2445/158574]

Exportar metadades

JSON - METS

Compartir registre